Kinaxo Biotechnologies GmbH has received a grant of about €1 million from Germany’s Ministry of Education and Research (BMBF) to develop a new way of quantifying small molecule-protein interactions by combining mass spectrometry with Kinaxo’s chemical proteomics technology platform, KinaTor.
